BioCryst Pharmaceuticals Inc
BCRXHealthcare|Drug Manufacturers - Specialty & Generic|USA
$10.45
-0.27 (-2.52%)
About
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Stock Price
+17.7%(1Y)
Pipeline Summary
57 total trials19
Phase 1
27
Phase 2
16
Phase 3
0
Phase 4
Active: 2Completed: 38Terminated: 11Recruiting: 1Withdrawn: 3APPROVED_FOR_MARKETING: 1ENROLLING_BY_INVITATION: 1
Active Trials (3)
A Study of Navenibart in Participants With Hereditary Angioedema
NCT06842823Hereditary Angioedema (HAE)
Phase 3Active
Enrollment: 157 participants
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
NCT06539507Netherton Syndrome
Phase 1Recruiting
Enrollment: 78 participants
Berotralstat Treatment in Children With Hereditary Angioedema
NCT05453968Hereditary Angioedema
Phase 3Active
Enrollment: 29 participants
BioScore
5.5/10
Watchlist
Ownership
Recent Insider Trades
McKee Amy ESELL
2026-05-1811,180 shares @ $8.97
Barnes Alane PSELL
2026-05-1362,500 shares @ $9.54
HEGGIE THERESASELL
2026-03-2049,933 shares @ $10.11
Barnes Alane PSELL
2026-03-16150,000 shares @ $9.15
Barnes Alane PSELL
2025-12-2221,773 shares @ $7.65
Recent News
2026-07-07 16:03:03
2026-07-01 00:36:40
2026-06-30 15:05:51
2026-06-30 13:02:43
2026-06-29 13:12:42
Data last updated: Jul 12, 2026, 07:40 PM